Genprex Inc (GNPX) concluded trading on Wednesday at a closing price of $0.29, with 42.63 million shares of worth about $12.36 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -18.44% during that period and on April 03, 2025 the price saw a gain of about 28.21%. Currently the company’s common shares owned by public are about 10.86M shares, out of which, 8.28M shares are available for trading.
Stock saw a price change of -22.37% in past 5 days and over the past one month there was a price change of -11.94%. Year-to-date (YTD), GNPX shares are showing a performance of -65.36% which decreased to -90.07% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.22 but also hit the highest price of $4.09 during that period. The average intraday trading volume for Genprex Inc shares is 2.05 million. The stock is currently trading -12.88% below its 20-day simple moving average (SMA20), while that difference is down -31.40% for SMA50 and it goes to -70.40% lower than SMA200.
Genprex Inc (NASDAQ: GNPX) currently have 10.86M outstanding shares and institutions hold larger chunk of about 3.42% of that.
The stock has a current market capitalization of $2.51M and its 3Y-monthly beta is at -0.35. It has posted earnings per share of -$8.35 in the same period. It has Quick Ratio of 0.83 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for GNPX, volatility over the week remained 28.71% while standing at 16.56% over the month.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by National Securities on January 26, 2021 offering a Buy rating for the stock and assigned a target price of $7 to it. Coverage by Noble Capital Markets stated Genprex Inc (GNPX) stock as an Outperform in their note to investors on April 29, 2019, suggesting a price target of $5 for the stock.
